ClinicalTrialsFinder

Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) Clinical Trials in Basel

1 recruitingBasel, Switzerland

Showing 1–1 of 1 trials

Recruiting
Early Phase 1

Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3)

Neuroendocrine Neoplasia's (NENs)Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
University Hospital, Basel, Switzerland16 enrolled1 locationNCT05359146